Durect Corporation

Multi-Dose NASH Clinical Trial Underway for Durect’s DUR-928
Multi-Dose NASH Clinical Trial Underway for Durect’s DUR-928
Xtalks
Durect Corporation
NASH
DUR-928
Flag link:
Top 3 Biotech Companies Awaiting FDA Approval
Top 3 Biotech Companies Awaiting FDA Approval
Investopedia
FDA
Pain Therapeutics
Durect Corporation
Remoxy
Progenics
Relistor
Flag link:
2014 Biotechnology Catalysts
2014 Biotechnology Catalysts
Seeking Alpha
Chelsea Therapeutics
Durect Corporation
EXACT Sciences
Vanda
Pozen
Progenics
MannKind
FDA
Flag link:
Pfizer: What Will Drive The Behemoth Forward?
Pfizer: What Will Drive The Behemoth Forward?
Seeking Alpha
Pfizer
Remoxy
Durect Corporation
Pain Therapeutics
Zogenix
Flag link:
FDA Accepts New Drug Application And Creates A Catalyst For Durect Corporation
FDA Accepts New Drug Application And Creates A Catalyst For Durect Corporation
Seeking Alpha
Durect Corporation
Posidur
post-operative pain
pain management
Flag link:
Where Is Pfizer Heading With The Patent Cliff?
Where Is Pfizer Heading With The Patent Cliff?
Seeking Alpha
Pfizer
patents
patent cliff
Acura Pharmaceuticals
Durect Corporation
Pain Therapeutics
Flag link:
Pfizer Spooks Durect Investors, Creates Opportunity
Pfizer Spooks Durect Investors, Creates Opportunity
Yahoo/Reuters
Pfizer
Durect Corporation
Remoxy
Flag link:
Durect Corporation: A Biopharma With No Debt
Durect Corporation: A Biopharma With No Debt
Seeking Alpha
Durect Corporation
Flag link:
3 Pharmaceutical Companies Seeing Insider Buys In Last 30 Days
3 Pharmaceutical Companies Seeing Insider Buys In Last 30 Days
Seeking Alpha
Enzon
Durect Corporation
OncoGenex
Flag link:
Durect reports Hospira returns rights to Posidur in U.S. and Canada
Durect reports Hospira returns rights to Posidur in U.S. and Canada
Yahoo/Fly on the Wall
Posidur
Canda
Durect Corporation
Hospira
Flag link:
Durect's partner Pfizer to end pain drug deal
Durect's partner Pfizer to end pain drug deal
Reuters
Pfizer
Durect Corporation
Eladur
Flag link:
Durect plunges 33% on failed drug study
Durect plunges 33% on failed drug study
Marketwatch
Durect Corporation
post-surgical pain
Posidur
Flag link:
Pain Management Stocks: Will This Painful Downturn End Soon?
Pain Management Stocks: Will This Painful Downturn End Soon?
Seeking Alpha
pain management
Acura Pharmaceuticals
Cumberland
Durect Corporation
Endo
Horizon Pharma
Pacira
Pain Therapeutics
Zogenix
Flag link:
Zogenix licenses once-a-month antipsychotic drug
Zogenix licenses once-a-month antipsychotic drug
Yahoo/AP
antipsychotics
Zogenix
Relday
Risperdal
JNJ
Durect Corporation
Flag link:
Busy Week for FDA Leads to Volatile Action in 5 Pharma Stocks
Busy Week for FDA Leads to Volatile Action in 5 Pharma Stocks
Seeking Alpha
FDA
Durect Corporation
Pain Therapeutics
Acura Pharmaceuticals
Lannett
Fibrocell Science
Flag link:
Pleasure And Pain For Pfizer
Pleasure And Pain For Pfizer
Investopedia
Pfizer
Pain Therapeutics
Durect Corporation
JNJ
Abbott Laboratories
Acura Pharmaceuticals
Flag link:
Pain Therapeutics, Durect Shares Plunge on Pain Drug Rejection
Pain Therapeutics, Durect Shares Plunge on Pain Drug Rejection
Minyanville,
Durect Corporation
Pain Therapeutics
Pfizer
Remoxy
FDA
Flag link:
The FDA's Drug Approval Agenda for Next Week
The FDA's Drug Approval Agenda for Next Week
Seeking Alpha
FDA
Xifaxan
Salix
IBS
Remoxy
Durect Corporation
Pain Therapeutics
Pfizer
painkillers
Flag link:
4 Pharma Stocks That Should See a Surge in Interest Next Week
4 Pharma Stocks That Should See a Surge in Interest Next Week
Seeking Alpha
Lannett
Durect Corporation
Fibrocell Science
Pain Therapeutics
Flag link:
Durect pain patch Eladur fails in midstage study on chronic lower back pain
Durect pain patch Eladur fails in midstage study on chronic lower back pain
Yahoo/AP
Eladur
pain patches
Durect Corporation
Flag link:

Pages